Direkt zum Inhalt
Merck
  • Evaluation of biotransformed berberine derivatives as anti inflammatory drugs: an in silico study.

Evaluation of biotransformed berberine derivatives as anti inflammatory drugs: an in silico study.

Interdisciplinary sciences, computational life sciences (2013-01-29)
Chandra D Naveen, G K Prasanth, C Sadasivan, M Haridas
ZUSAMMENFASSUNG

The anti inflammatory potential of the human and microbial biotransformed derivatives of berberine were determined by molecular docking. It was revealed that almost all derivatives formed as a result of biotransformation showed increase in phospholipase A(2) binding affinity compared to berberine. The newly introduced -OH group/groups establish stronger hydrogen bonding interactions and more number of van der Waals contacts with the protein. As phospholipase A(2) is a target of anti inflammatory drugs, it might be concluded that certain biotransformed derivatives of berberine could be better anti inflammatory agents compared to berberine.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Phospholipase A2 aus Honigbienengift (Apis mellifera), salt-free, lyophilized powder, 600-2400 units/mg protein
Sigma-Aldrich
Phospholipase A2 aus Schweinepankreas, ammonium sulfate suspension, ≥600 units/mg protein
Sigma-Aldrich
Phospholipase A2 aus Rinderpankreas, lyophilized powder, ≥20 units/mg protein